Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial

by Fountzilas George, Panagiotou Petros, Markopoulos Christos, Stratigos Alexandros, Polyzos Aristidis, Tsoutsos Dimosthenis, Pectasides Eirini, Buchbinder Elizabeth, Metaxas Yannis, Spyropoulou-Vlachou Maria, Koon Henry, Dafni Urania, Gogas Helen, Castana Ourania, Skarlos Pantelis, Atkins Michael B, Kirkwood John M
Published 2010-11-01